Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
That’s compared with HIV-negative men.
This was among a small group of people who contracted the virus within one year, most of whom had HIV as well.
An analysis of people diagnosed with recently contracted HIV in the state revealed many missed opportunities.
However, various disparities based on race and insurance type persist.
A survey of Australian men who have sex with men conducted in 2016 found a low proportion trusted HIV treatment as prevention of the virus.
A recent analysis of a group of HIV-positive individuals age 50 and older found that nearly half had potential conflicts.
An Australian study found that a recent spike in PrEP use coincided with a swift drop in condom use among both those on and off PrEP.
However, the majority of children with HIV in the 20 highest burden nations still aren’t on antiretrovirals.
An alarmingly high proportion of the HIV population is apparently at risk of prescription pill–driven opioid addiction.
Those on Tybost-boosted Vitekta are more than twice as likely as those taking Tivicay to switch meds because of adverse health events.
This finding, from a review of eight studies of 4,400 gay & bi men, suggests this group lowers condom use for anal sex after starting PrEP.
These risks include hospitalization and death.
Lucemyra is approved to treat the symptoms of opioid withdrawal for 14 days.
Researchers identified treatment with Kaletra (lopinavir/ritonavir) as a risk factor.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.